Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albis for Prevention of GI Hemorrhage in Pancreatic Cancer CCRT
NCT02570529Phase 4Withdrawn
- Sponsor
- Yonsei University
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Albis in Peptic ulcer disease (PUD), Gastrointestinal Bleeding (GIB), sponsored by Yonsei University. Planned start Oct 2015; status: withdrawn.
02
Drugs
Albis
03
Conditions
Peptic ulcer disease (PUD)Gastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT02570529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570529.